These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 6246410

  • 1. Marihuana for nausea and vomiting due to cancer chemotherapy.
    Med Lett Drugs Ther; 1980 May 16; 22(10):41-3. PubMed ID: 6246410
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synthetic marijuana for nausea and vomiting due to cancer chemotherapy.
    Med Lett Drugs Ther; 1985 Nov 22; 27(701):97-8. PubMed ID: 2999571
    [No Abstract] [Full Text] [Related]

  • 4. The medical use of marijuana: the case for clinical trials.
    Doblin R, Kleiman MA.
    J Addict Dis; 1995 Nov 22; 14(1):5-14. PubMed ID: 7543287
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [A marihuana component for nausea and vomiting induced by chemo- and radiotherapy].
    Gez E, Biran S, Fuks Z, Edelstein E, Lander N, Mechoulam R.
    Harefuah; 1983 Nov 15; 105(10):306-8. PubMed ID: 6323286
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacology. Counteracting side-effects.
    Donovan A.
    Nurs Mirror; 1985 Oct 02; 161(14):38-9. PubMed ID: 2995930
    [No Abstract] [Full Text] [Related]

  • 9. Levonantradol: a synthetic cannabinoid in the treatment of severe chemotherapy-induced nausea and vomiting resistant to conventional anti-emetic therapy.
    Stuart-Harris RC, Mooney CA, Smith IE.
    Clin Oncol; 1983 Jun 02; 9(2):143-6. PubMed ID: 6309451
    [Abstract] [Full Text] [Related]

  • 10. Prevention of chemotherapy-induced nausea and vomiting in patients with cancer.
    Aapro MS.
    Ariz Med; 1981 Nov 02; 38(11):843-5. PubMed ID: 6274276
    [No Abstract] [Full Text] [Related]

  • 11. Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.
    Drug Ther Bull; 1984 Feb 10; 22(3):9-11. PubMed ID: 6321126
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Necessary risks.
    Jarvik ME.
    N Engl J Med; 1979 Jun 07; 300(23):1330. PubMed ID: 440336
    [No Abstract] [Full Text] [Related]

  • 15. Dolasetron for prevention of nausea and vomiting due to cancer chemotherapy.
    Med Lett Drugs Ther; 1998 May 08; 40(1026):53-4. PubMed ID: 9599596
    [No Abstract] [Full Text] [Related]

  • 16. Cannabinoids in the management of intractable chemotherapy-induced nausea and vomiting and cancer-related pain.
    Sutton IR, Daeninck P.
    J Support Oncol; 2006 May 08; 4(10):531-5. PubMed ID: 17136871
    [No Abstract] [Full Text] [Related]

  • 17. [The management of vomiting and nausea with zofran during the chemotherapy of malignant tumors].
    Seliuzhitskiĭ IV, Eliseev SN, Ivanov AI.
    Voen Med Zh; 1994 Oct 08; (10):34-6. PubMed ID: 7831851
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ondansetron, an antagonist of 5-HT3 receptors, in the treatment of antineoplastic drug-induced nausea and vomiting in children.
    Matera MG, Di Tullio M, Lucarelli C, Casale F, Calabria C, Lampa E, Indolfi P, Rossi F.
    J Med; 1993 Oct 08; 24(2-3):161-70. PubMed ID: 7691978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.